mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.3 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.3 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |